Drug
Azzalure OR Dysport
Azzalure OR Dysport: highest development phase Post-Market, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Azzalure or Dysport NCT02297516 | Post-Market | Aesthetics |
Latest
No recent events.
Follow Azzalure OR Dysport on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.